Latest Administration News

Mesoblast has secured FDA agreement on key requirements for its Biologics License Application for Revascor, targeting ischemic heart failure patients with reduced ejection fraction. The company aims for accelerated approval by year-end 2025.

InvestSMART Funds Management has updated the Distribution Reinvestment Plan rules for the Intelligent Investor Equity Growth Fund Active ETF, effective July 1, 2025, enhancing unitholder flexibility and fund capital management.

Optiscan Imaging Ltd has commenced a landmark clinical study at Royal Melbourne Hospital, testing its cutting-edge InVue® and InForm™ devices to improve breast cancer surgery precision. The study aims to generate critical data for US FDA approval and could redefine surgical oncology workflows.

Magnetite Mines has increased its Razorback Iron Ore Project resource estimate and is advancing strategic partnerships, while early saline water testwork shows promise for green iron production.

South Harz Potash Ltd has announced a pro-rata non-renounceable entitlement issue to raise approximately A$1.28 million, offering one new share for every three held plus free options. The capital raise aims to fund its dual-asset growth plans in Germany amid ongoing project development and acquisition efforts.

Actinogen Medical has enrolled its 100th participant in the XanaMIA phase 2b/3 Alzheimer’s trial, setting the stage for a critical interim analysis in January 2026 and final results by year-end.

Inventis Limited has placed its commercial furniture division into voluntary administration, triggering a default event with its lender and prompting negotiations on financial restructuring.

Epsilon Healthcare and its subsidiaries have officially exited voluntary administration and Deeds of Company Arrangement, marking a pivotal recovery milestone supported by significant personal commitments from the new board. The company now shifts focus to strategic growth and rebuilding trust.

State Street Global Advisors has announced a substantial cash distribution for the SPDR S&P/ASX 200 ESG ETF, reflecting the fund’s income and tax attributes for the year ending June 2025.

State Street Global Advisors has announced a 21.5897 cents per unit cash distribution for the SPDR S&P/ASX Small Ordinaries ETF for the period ending June 30, 2025, alongside franking and foreign tax credits.

State Street Global Advisors has announced a 31.56 cents per unit cash distribution for the SPDR S&P/ASX 200 Listed Property ETF for the period ending June 30, 2025, including franking and foreign tax credits.

State Street Global Advisors announces a substantial cash distribution for the SPDR S&P World ex Australia Carbon Aware ETF, highlighting a blend of income and tax credits for investors.